Biodexa Pharmaceuticals (LON:MTPH) Stock Price Passes Above 50 Day Moving Average of $18.00

Biodexa Pharmaceuticals Plc (LON:MTPH)’s stock price crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 18 ($0.24) and traded as high as GBX 20 ($0.26). Biodexa Pharmaceuticals shares last traded at GBX 18 ($0.24), with a volume of 73,672 shares traded.

Biodexa Pharmaceuticals Stock Performance

The company’s 50 day moving average price is GBX 18 and its 200 day moving average price is GBX 18. The firm has a market cap of £31.20 million, a PE ratio of -21.95 and a beta of 1.22. The company has a debt-to-equity ratio of 9.52, a current ratio of 5.28 and a quick ratio of 5.28.

Biodexa Pharmaceuticals Company Profile

Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection.